Dempo K, Satoh M, Tsuji S, Mori M, Kuroki Y, Akino T
Department of Pathology, Sapporo Medical College, Japan.
Pathol Res Pract. 1987 Oct;182(5):669-75.
To reevaluate the expression of pulmonary surfactant apoproteins in lung carcinomas, cancerous tissues from 47 cases were immunohistochemically examined by the avidin-biotin peroxidase complex method using monoclonal antibodies. These antibodies recognized apoproteins in type II pneumocytes in normal and in hyperplastic alveoli and nonciliated columnal cells (Clara cells) in terminal bronchioles of noncancerous tissues. Cancer cells positive for surfactant apoproteins were observed in 11 out of 33 adenocarcinomas, including 1 case of bronchioloalveolar carcinoma. Interestingly, two cases of adenocarcinomas with ultrastructural features of Clara cells, which had metastatic lesions, were positively stained both in the primary and the metastatic sites. Two out of 4 adenosquamous carcinomas showed positive reaction, which was exclusively localized in the cells with papillary structure. The present study indicates that the expression of surfactant apoproteins in cancer cells occurs ubiquitously in adenocarcinomas, which are considered to be derived from the terminal air way.
为了重新评估肺癌中肺表面活性物质载脂蛋白的表达情况,采用抗生物素蛋白-生物素过氧化物酶复合物法,使用单克隆抗体对47例癌组织进行免疫组织化学检查。这些抗体可识别正常及增生性肺泡中Ⅱ型肺细胞以及非癌组织终末细支气管中的无纤毛柱状细胞(克拉拉细胞)中的载脂蛋白。在33例腺癌中的11例中观察到表面活性物质载脂蛋白阳性的癌细胞,其中包括1例细支气管肺泡癌。有趣的是,2例具有克拉拉细胞超微结构特征且有转移灶的腺癌,其原发灶和转移灶均呈阳性染色。4例腺鳞癌中有2例呈阳性反应,且仅局限于具有乳头状结构的细胞中。本研究表明,表面活性物质载脂蛋白在癌细胞中的表达在腺癌中普遍存在,腺癌被认为起源于终末气道。